<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on May 29, 2018</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT02376361</url>
  </required_header>
  <id_info>
    <org_study_id>20140235</org_study_id>
    <nct_id>NCT02376361</nct_id>
  </id_info>
  <brief_title>Hemodialysis Access Surveillance Evaluation Study</brief_title>
  <acronym>HASE</acronym>
  <official_title>Hemodialysis Access Surveillance Evaluation Study</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Albany Medical College</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
    <collaborator>
      <agency>Transonic Systems Inc.</agency>
      <agency_class>Industry</agency_class>
    </collaborator>
  </sponsors>
  <source>Albany Medical College</source>
  <oversight_info>
    <has_dmc>No</has_dmc>
  </oversight_info>
  <brief_summary>
    <textblock>
      The purpose of the study is to learn if monitoring dialysis access blood flow during dialysis
      treatment with a transonic machine (an ultrasound technique) will prevent (or reduce) the
      development of dialysis access thrombosis (clotting).

      Investigators would like to study if monitoring with a specific technique called ultrasound
      dilution technique can help prevent problems with access when compared to what is the current
      standard of care for patients.
    </textblock>
  </brief_summary>
  <overall_status>Recruiting</overall_status>
  <start_date>March 2015</start_date>
  <completion_date type="Anticipated">August 2020</completion_date>
  <primary_completion_date type="Anticipated">August 2020</primary_completion_date>
  <phase>N/A</phase>
  <study_type>Interventional</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <allocation>Randomized</allocation>
    <intervention_model>Parallel Assignment</intervention_model>
    <primary_purpose>Screening</primary_purpose>
    <masking>Single (Outcomes Assessor)</masking>
  </study_design_info>
  <primary_outcome>
    <measure>Difference in hemodialysis access thrombosis rate</measure>
    <time_frame>Up to 24 months</time_frame>
    <description>Evaluate the reduction of hemodialysis access thrombosis rate</description>
  </primary_outcome>
  <secondary_outcome>
    <measure>Difference in tunneled hemodialysis catheter rate</measure>
    <time_frame>Up to 24 months</time_frame>
    <description>Evaluate the reduction of tunneled hemodialysis catheter rate</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Difference in tunneled hemodialysis catheter duration</measure>
    <time_frame>Up to 24 months</time_frame>
    <description>Evaluate the reduction of tunneled hemodialysis catheter duration</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Difference in hemodialysis access thrombectomy procedures</measure>
    <time_frame>Up to 24 months</time_frame>
    <description>Evaluate the reduction of hemodialysis access thrombectomy procedures</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Difference in hemodialysis access angiogram and angioplasty procedures</measure>
    <time_frame>Up to 24 months</time_frame>
    <description>Evaluate the reduction of hemodialysis access angiogram and angioplasty procedures</description>
  </secondary_outcome>
  <number_of_arms>2</number_of_arms>
  <enrollment type="Anticipated">886</enrollment>
  <condition>Hemodialysis Access</condition>
  <condition>Thrombosis</condition>
  <arm_group>
    <arm_group_label>Surveillance Group</arm_group_label>
    <arm_group_type>Active Comparator</arm_group_type>
    <description>Monthly blood flow surveillance by ultrasound dilution technique and standard of care.</description>
  </arm_group>
  <arm_group>
    <arm_group_label>Control Group</arm_group_label>
    <arm_group_type>No Intervention</arm_group_type>
    <description>Control group will receive standard monitoring (standard care).</description>
  </arm_group>
  <intervention>
    <intervention_type>Device</intervention_type>
    <intervention_name>Transonic</intervention_name>
    <description>Access recirculation, access flow would be determined using the ultrasound dilution technique (Transonic system).
Within 90 min of the beginning of HD session HD03 sensors are clamped HD tubing lines
Recirculation, access flow will be performed according to HD03 Manual.
Post intervention evaluation is as per each arm follow up unless other follow up deemed necessary by the interventionalist.</description>
    <arm_group_label>Surveillance Group</arm_group_label>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:

          -  Chronic hemodialysis patients undergoing dialysis therapy via an upper extremity
             arteriovenous access (arteriovenous fistula or an arteriovenous graft) will be
             enrolled to have monthly surveillance flow measurement using Transonic system or
             physical examination of the arteriovenous access by qualified person at least once a
             month for a period of 2 years.

        Exclusion Criteria:

          -  Patients requiring surgical intervention on the arteriovenous access.

          -  History of access thrombosis (one or more access thrombosis of the current
             arteriovenous access).

          -  Patients with signs of access infection.

          -  Patients with a malignancy.

          -  Patients with life expectancy of less than six months.

          -  Unable to understand the study.

          -  Unable to sign the consent form.

          -  Patients with psychiatric disorder.

          -  Age less than 18 or greater than 80 years.

          -  Adults unable to consent

          -  Individuals who are not yet adults (infants, children, teenagers)

          -  Pregnant women

          -  Prisoners
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>18 Years</minimum_age>
    <maximum_age>80 Years</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Loay Salman, MD</last_name>
    <role>Principal Investigator</role>
    <affiliation>University of Miami</affiliation>
  </overall_official>
  <overall_contact>
    <last_name>Ivy Machado, RN</last_name>
    <phone>786-473-0802</phone>
    <email>Ixm136@med.miami.edu</email>
  </overall_contact>
  <location>
    <facility>
      <name>North America Research Institute</name>
      <address>
        <city>Azusa</city>
        <state>California</state>
        <zip>91702</zip>
        <country>United States</country>
      </address>
    </facility>
    <status>Completed</status>
  </location>
  <location>
    <facility>
      <name>University of Miami Miller School of Medicine</name>
      <address>
        <city>Miami</city>
        <state>Florida</state>
        <zip>33136</zip>
        <country>United States</country>
      </address>
    </facility>
    <status>Completed</status>
  </location>
  <location>
    <facility>
      <name>Albany Medical College</name>
      <address>
        <city>Albany</city>
        <state>New York</state>
        <zip>12208</zip>
        <country>United States</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Nicolle Bateman</last_name>
      <phone>518-456-2429</phone>
      <email>nbateman@dciinc.org</email>
    </contact>
    <contact_backup>
      <last_name>Christina Manning</last_name>
      <phone>518-262-6323</phone>
      <email>manninc@mail.amc.edu</email>
    </contact_backup>
  </location>
  <location_countries>
    <country>United States</country>
  </location_countries>
  <verification_date>October 2017</verification_date>
  <!-- For several months we've had both old and new date name tags                             -->
  <!-- Now, the old date names have been dropped.                                               -->
  <!-- The new date name replacements are:                                                      -->
  <!--     OLD (gone)                                        NEW (in use)                       -->
  <!--   lastchanged_date                         becomes   last_update_submitted               -->
  <!--   firstreceived_date                       becomes   study_first_submitted               -->
  <!--   firstreceived_results_date               becomes   results_first_submitted             -->
  <!--   firstreceived_results_disposition_date   becomes   disposition_first_submitted         -->
  <study_first_submitted>February 24, 2015</study_first_submitted>
  <study_first_submitted_qc>February 24, 2015</study_first_submitted_qc>
  <study_first_posted type="Estimate">March 3, 2015</study_first_posted>
  <last_update_submitted>October 10, 2017</last_update_submitted>
  <last_update_submitted_qc>October 10, 2017</last_update_submitted_qc>
  <last_update_posted type="Actual">October 11, 2017</last_update_posted>
  <responsible_party>
    <responsible_party_type>Principal Investigator</responsible_party_type>
    <investigator_affiliation>Albany Medical College</investigator_affiliation>
    <investigator_full_name>Loay Salman, MD</investigator_full_name>
    <investigator_title>Professor of Medicine</investigator_title>
  </responsible_party>
  <keyword>Surveillance</keyword>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Thrombosis</mesh_term>
  </condition_browse>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

